Cargando…

ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study

Detalles Bibliográficos
Autores principales:	Ray, Joel G., Vermeulen, Marian J., Schull, Michael J., Park, Alison L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	COVID-19 Consensus
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040562/ https://www.ncbi.nlm.nih.gov/pubmed/33827287 http://dx.doi.org/10.1177/10760296211008986

Ejemplares similares

COVID‐19 and ABO blood group: another viewpoint
por: Gérard, Christiane, et al.
Publicado: (2020)

Deep Venous Thrombosis in COVID-19 Patients: A Cohort Analysis
por: Cai, Chuanqi, et al.
Publicado: (2020)

The Impact of Prior Antithrombotic use on Thromboembolic Events in Patients with Cardiovascular Disease and Severe COVID-19 Infection
por: Bouchlarhem, Amine, et al.
Publicado: (2022)

The Efficacy and Safety of Prolonged Oral Anticoagulation for the Prevention of Thromboembolic Events in Patients Recovered From COVID-19 1 Year After Hospital Discharge: The SARCOV-19 Prospective Registry
por: Aidouni, Ghizlane El, et al.
Publicado: (2023)

Risk and Management of Venous Thromboembolism in Patients with COVID-19
por: Skeik, Nedaa, et al.
Publicado: (2021)

Characteristics of Venous Thromboembolism in COVID-19 Patients: A Multicenter Experience from Northern Italy
por: Marone, Enrico M., et al.
Publicado: (2020)

Arterial and venous thromboembolism in critically ill, COVID 19 positive patients admitted to Intensive Care Unit
por: Elboushi, Amro, et al.
Publicado: (2022)

Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020
por: Ramacciotti, Eduardo, et al.
Publicado: (2020)

Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS‐CoV‐2 positivity
por: Quaresima, Micol, et al.
Publicado: (2020)

COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets
por: Cure, Erkan, et al.
Publicado: (2020)

Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients
por: Yu, Yuan, et al.
Publicado: (2020)

Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan
por: Chen, Jianpu, et al.
Publicado: (2020)

Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications
por: Haimei, MA
Publicado: (2020)

Clinical Outcomes of Pulmonary Embolism in Mexican Patients With COVID-19
por: Bobadilla-Rosado, Luis O., et al.
Publicado: (2021)

Non-ABO red cell antibodies and risk of COVID-19
por: Ray, Joel G., et al.
Publicado: (2021)

ABO blood group type and risk of venous thromboembolism in patients with cancer
por: Englisch, Cornelia, et al.
Publicado: (2022)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: A Dutch, multicenter, matched-cohort clinical study
por: Jonker, Pascal K.C., et al.
Publicado: (2021)

Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy
por: Bozzani, Antonio, et al.
Publicado: (2020)

Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries
por: Verberk, Janneke D. M., et al.
Publicado: (2022)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group
por: Ray, Joel G., et al.
Publicado: (2021)

SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study
por: Ray, Joel G, et al.
Publicado: (2022)

Thoracic sarcopenia as a predictive factor of SARS-COV2 evolution
por: Koehler, J., et al.
Publicado: (2022)

Antidiabetes Agents against Sars-Cov-2 Infection
por: Vitiello, Antonio, et al.
Publicado: (2020)

Re-reading the SARS-COV-2 Epidemic in Bergamo
por: Schena, Daniele, et al.
Publicado: (2020)

SARS-CoV-2 infections in professional orchestra and choir musicians—a prospective cohort study
por: Berghöfer, Anne, et al.
Publicado: (2022)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

SG-APSIC1126: Controlling SARS-CoV-2 infection in inpatients through a grouping system at Ho Chi Minh Children’s Hospital 1 in Vietnam
por: Minh, Chau Nguyen Ngoc, et al.
Publicado: (2023)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

Nutritional status in post SARS-Cov2 rehabilitation patients
por: Gobbi, M., et al.
Publicado: (2022)

Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real
por: Bordejé Laguna, Luisa, et al.
Publicado: (2022)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

Arterial thromboembolic complications in COVID‐19 in low‐risk patients despite prophylaxis
por: Griffin, Daniel O., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a42r29jchfair7unq8c9m12l4h